Ibu and Central nervous system lesion - a phase IV clinical study of FDA data
Summary:
Central nervous system lesion is reported as a side effect among people who take Ibu (ibuprofen), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Gilenya, and have Multiple sclerosis.
The phase IV clinical study analyzes which people have Central nervous system lesion when taking Ibu. It is created by eHealthMe based on reports of 240,078 people who have side effects when taking Ibu from the FDA, and is updated regularly.
What is Ibu?
Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,531 Ibu users. Check the latest studies of Ibu.
What is Central nervous system lesion?
Central nervous system lesion (an abnormality in tissue of brain or spinal cord) is found to be associated with 779 drugs and 824 conditions by eHealthMe. Check the latest studies of Central nervous system lesion.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
240,078 people reported to have side effects when taking Ibu.
Among them, 299 people (0.12%) have Central nervous system lesion.
Among these 299 people:
How long have people been on Ibu when they have Central nervous system lesion? *
What is the gender of people who have Central nervous system lesion when taking Ibu? *
What is the age of people who have Central nervous system lesion when taking Ibu? *
What are other drugs people take besides Ibu? *
What are other side effects people have besides Central nervous system lesion? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ibu and have Central nervous system lesion?
- Check whether Central nervous system lesion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ibu:
- Ibu (246,531 reports)
Central nervous system lesion treatments and more:
- Central nervous system lesion (17,008 reports)
How severe was Central nervous system lesion and when was it recovered:
Expand to all the drugs that have ingredients of ibuprofen:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ibu:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Central nervous system lesion:
- Central nervous system lesion (779 drugs)
Browse all the conditions that are associated with Central nervous system lesion:
- Central nervous system lesion (824 conditions)
Related publications that referenced our studies
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Ibu) and Ibu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vicodin and Itchiness for Women aged 20-29 - 8 seconds ago
- Vicodin and Pruritus for Women aged 20-29 - 8 seconds ago
- Vicodin and Itching for Women aged 20-29 - 9 seconds ago
- Could Atorvastatin Calcium cause Generalised Oedema? - 14 seconds ago
- Rashes in Tricor, how severe and when it was recovered? - 24 seconds ago
- Farxiga vs. Novolog Flexpen, side effect and effectiveness comparison - a minute ago
- How effective is Cetirizine Hydrochloride Allergy for Allergic Sinusitis? - a minute ago
- Could Mounjaro cause Blister? - 2 minutes ago
- Could Nexium cause Xerosis? - 2 minutes ago
- Could Methylene Blue cause Hyperreflexia? - 2 minutes ago